HPE and AMD Power Complex Scientific Discovery in World’s Fastest Supercomputer

HPE and AMD Power Complex Scientific Discovery in World’s Fastest Supercomputer

The DOE’s El Capitan will use next-generation AMD EPYC processors, codenamed “Genoa” featuring the “Zen 4” processor core, next-generation AMD Radeon Instinct GPUs, based on a new compute-optimized architecture, and the 3rd Generation AMD Infinity Architecture, which will provide a high-bandwidth, low latency connection between the CPUs and GPUs.

Strengthening Nation’s Nuclear Stockpile, Security and Defense with Exascale Technologies 

“As an industry and as a nation, we have achieved a major milestone in computing. HPE is honored to support the U.S. Department of Energy and Lawrence Livermore National Laboratory in a critical strategic mission to advance the United States’ position in security and defense,” said Peter Ungaro, senior vice president, and general manager, HPC and Mission Critical Systems (MCS), at HPE. 

HPE’s Cray Shasta technologies, which were built from the ground up to support a diverse set of processor and accelerator technologies to meet new levels of performance and scalability, will enable the DOE’s El Capitan to meet NNSA requirements, which include the NNSA’s Life Extension Program (LEP), a critical part of stockpile stewardship that aims to modernize aging weapons in the U.S. nuclear stockpile that are to remain safe, secure, and effective.

LLNL researchers will use the system to explore new applications that integrate AI and machine learning into HPC workloads and is already applying HPE supercomputing and AI solutions to make breakthroughs in medical and drug research initiatives, including:

Accelerating cancer drug discovery from six years to one year through a partnership with GlaxoSmithKline (gsk), a multinational pharmaceutical company, the National Cancer Institute, and other DOE national laboratories through the ATOM consortium.

Understanding the dynamics and mutations of RAS proteins that are linked to 30% of human cancers by collaborating with The National Cancer Institute and other partner institutions.

Breaking Speed Barrier with 2 Exaflops